Year: 2022
Type: article
Study design: Observational Study
Abstract: Context Blood pressure and plasma catecholamines normally decline during sleep and rapidly increase in early morning. This is blunted in adults with type 2 diabetes (T2D). Objective We hypothesize that increased sympatho-adrenal activity during sleep differentiates youth with T2D from nondiabetic obese youth and lean youth. Methods Fasting spot morning and 24-hour urines were collected in obese adolescents with and without T2D, and normal-weight controls. Fractionated free urine catecholamines (epinephrine, norepinephrine, and dopamine) were measured, and the ratio of fasting spot morning to 24-hour catecholamines was calculated. Results Urinary 24-hour catecholamine levels were comparable across the 3 groups. Fasting morning epinephrine and the ratio of fasting morning/24-hour epinephrine were higher in youth with T2D (P = 0.004 and P = 0.035, respectively). In males, the ratio of fasting morning/24-hour epinephrine was also higher in youth with T2D (P = 0.005). In females, fasting morning norepinephrine and the ratio of fasting morning/24-hour dopamine were lower in obese youth with and without T2D (P = 0.013 and P = 0.005, respectively) compared with lean youth. Systolic blood pressure was higher in diabetic participants than other groups; males trended higher than females. Conclusion Circadian rhythm in catecholamines is disrupted in youth-onset T2D, with a blunted overnight fall in urinary epinephrine in males. Conversely, fasting morning norepinephrine and dopamine levels were lower in obese females with or without T2D. Higher nocturnal catecholamines in males with T2D might associate with, or predispose to, hypertension and cardiovascular complications. Lower catecholamine excretion in females with obesity might serve an adaptive, protective role.
Source: Journal of the Endocrine Society
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,822
Funders: U.S. Department of Agriculture, Strong, Louisiana Clinical and Translational Science Center, Children's Miracle Network Hospitals, National Institutes of Health, Nutrition Obesity Research Center, University of North Carolina, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Serotonin as a Novel Biomarker for Progression to Type 2 Diabetes in Obese Adolescents, G1614576642, G197698696, G2820923697, G305254594, G3667826151, G4370236196, G5520236917, G5850863802, Predicting Newborn and Childhood Adiposity: An Integrated Omics Approach, G7125314047, G8477750575, G8868582356, G9000311072, Biomarkers of Dietary Intake and Exposure Data Coordinating Center, Louisiana Clinical and Translational Science Center, Pennington/Louisiana NORC, North Carolina Diabetes Research Center
OpenAlex ID: W4312136985
